---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-025565"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:55:23.158897+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pieris issues special voting preferred to Chairman to secure authorized share increase vote

## Summary
- Issued 1 share of Series F Preferred to Chairman James Geraghty for $1 cash; preferred has 25M votes.
- Preferred votes only on proposal to increase authorized common shares, in proportion to common votes.
- No conversion, dividends, or liquidation rights; redeemable for $0.01 upon authorized share increase or Board order.
- The authorized share increase is to facilitate the proposed merger with Palvella Therapeutics.
- The preferred ensures a favorable vote on the authorized share increase, a key step in the merger.

## SEC filing metadata
- accession: 0001437749-24-025565
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/0001437749-24-025565-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924025565/pirs20240807_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-025565
- JSON: https://secwatch.observer/filing/0001437749-24-025565.json
- Plain text: https://secwatch.observer/filing/0001437749-24-025565.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.